Eric I. Campos

2.9k total citations · 1 hit paper
29 papers, 2.0k citations indexed

About

Eric I. Campos is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eric I. Campos has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Eric I. Campos's work include Epigenetics and DNA Methylation (9 papers), Genomics and Chromatin Dynamics (9 papers) and Ubiquitin and proteasome pathways (7 papers). Eric I. Campos is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Genomics and Chromatin Dynamics (9 papers) and Ubiquitin and proteasome pathways (7 papers). Eric I. Campos collaborates with scholars based in Canada, United States and United Kingdom. Eric I. Campos's co-authors include Danny Reinberg, James M. Stafford, Gang Li, Mei Yieng Chin, Wen‐Hung Kuo, Gang Li, Marco Garate, Ronald P.C. Wong, Magdalena Martinka and Yemin Wang and has published in prestigious journals such as Nature, Molecular Cell and Journal of Virology.

In The Last Decade

Eric I. Campos

28 papers receiving 2.0k citations

Hit Papers

Histones: Annotating Chromatin 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric I. Campos Canada 19 1.8k 254 192 188 159 29 2.0k
Sylvain Daujat France 21 2.6k 1.5× 304 1.2× 301 1.6× 266 1.4× 208 1.3× 24 3.0k
Hetian Lei China 24 1.1k 0.6× 158 0.6× 136 0.7× 160 0.9× 160 1.0× 82 1.9k
Tari Parmely United States 14 1.4k 0.8× 241 0.9× 183 1.0× 183 1.0× 236 1.5× 20 2.0k
Alessandro Cuomo Italy 24 1.8k 1.0× 350 1.4× 150 0.8× 250 1.3× 252 1.6× 48 2.3k
Lee Jamieson United States 17 1.6k 0.9× 490 1.9× 110 0.6× 244 1.3× 137 0.9× 21 2.2k
Odd S. Gabrielsen Norway 25 1.8k 1.0× 212 0.8× 281 1.5× 133 0.7× 191 1.2× 66 2.1k
Philippe Coulombe France 23 2.2k 1.3× 459 1.8× 205 1.1× 210 1.1× 180 1.1× 30 2.5k
Barry M. Zee United States 24 2.3k 1.3× 201 0.8× 187 1.0× 168 0.9× 113 0.7× 42 2.6k
Chieri Tomomori‐Sato United States 19 1.9k 1.0× 236 0.9× 237 1.2× 135 0.7× 124 0.8× 24 2.3k
Jolanta Polanowska France 21 1.5k 0.9× 311 1.2× 212 1.1× 164 0.9× 82 0.5× 32 1.8k

Countries citing papers authored by Eric I. Campos

Since Specialization
Citations

This map shows the geographic impact of Eric I. Campos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric I. Campos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric I. Campos more than expected).

Fields of papers citing papers by Eric I. Campos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric I. Campos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric I. Campos. The network helps show where Eric I. Campos may publish in the future.

Co-authorship network of co-authors of Eric I. Campos

This figure shows the co-authorship network connecting the top 25 collaborators of Eric I. Campos. A scholar is included among the top collaborators of Eric I. Campos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric I. Campos. Eric I. Campos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Cassandra J., Carrie-Lynn M. Soltys, Riyana Babul‐Hirji, et al.. (2023). CYP26B1-related disorder: expanding the ends of the spectrum through clinical and molecular evidence. Human Genetics. 142(11). 1571–1586. 9 indexed citations
2.
Siddaway, Robert, Sanja Pajovic, Étienne Coyaud, et al.. (2022). Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma. Acta Neuropathologica. 144(5). 1027–1048. 17 indexed citations
3.
Dyakov, Boris J.A., Mila Mirceta, Christopher E. Pearson, et al.. (2021). ATRX proximal protein associations boast roles beyond histone deposition. PLoS Genetics. 17(11). e1009909–e1009909. 12 indexed citations
4.
Alerasool, Nader, Zhen-Yuan Lin, Jessica Lacoste, et al.. (2021). Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains. Molecular Cell. 81(12). 2549–2565.e8. 51 indexed citations
5.
Campos, Eric I., et al.. (2020). Interactions With Histone H3 & Tools to Study Them. Frontiers in Cell and Developmental Biology. 8. 701–701. 18 indexed citations
6.
Jansen, Pascal W.T.C., et al.. (2019). The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice. Molecular Cancer Research. 17(7). 1468–1479. 4 indexed citations
7.
Campos, Eric I., Arne H. Smits, Young‐Hoon Kang, et al.. (2015). Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. Molecular Cell. 60(4). 697–709. 53 indexed citations
8.
Campos, Eric I., James M. Stafford, & Danny Reinberg. (2014). Epigenetic inheritance: histone bookmarks across generations. Trends in Cell Biology. 24(11). 664–674. 103 indexed citations
9.
Kanno, Tomohiko, Yuka Kanno, Gary LeRoy, et al.. (2014). BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nature Structural & Molecular Biology. 21(12). 1047–1057. 239 indexed citations
10.
Li, Ji, Vincenzo D’Angiolella, E. Scott Seeley, et al.. (2013). USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110. Nature. 495(7440). 255–259. 105 indexed citations
11.
Campos, Eric I., Jeffrey Fillingham, Guohong Li, et al.. (2010). The program for processing newly synthesized histones H3.1 and H4. Nature Structural & Molecular Biology. 17(11). 1343–1351. 195 indexed citations
12.
Garate, Marco, Ronald P.C. Wong, Eric I. Campos, Yemin Wang, & Gang Li. (2008). NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33 ING1b. EMBO Reports. 9(6). 576–581. 62 indexed citations
13.
Wang, Yemin, et al.. (2007). The ING1b tumor suppressor facilitates nucleotide excision repair by promoting chromatin accessibility to XPA. Experimental Cell Research. 313(8). 1628–1638. 33 indexed citations
14.
Zhou, Youwen, Derek L. Dai, Magdalena Martinka, et al.. (2005). Osteopontin Expression Correlates with Melanoma Invasion. Journal of Investigative Dermatology. 124(5). 1044–1052. 4 indexed citations
16.
Campos, Eric I., et al.. (2004). Generation of a Polyclonal Antibody Specifically Against the p33ING1bTumor Suppressor. Journal of Immunoassay and Immunochemistry. 25(1). 71–80. 2 indexed citations
17.
Campos, Eric I., et al.. (2004). Biological functions of the ING family tumor suppressors. Cellular and Molecular Life Sciences. 61(19-20). 2597–2613. 91 indexed citations
18.
Ng, Kin Cheung, Eric I. Campos, Magdalena Martinka, & Gang Li. (2004). XAF1 Expression Is Significantly Reduced in Human Melanoma. Journal of Investigative Dermatology. 123(6). 1127–1134. 56 indexed citations
19.
Dai, Derek L., Nikita Makretsov, Eric I. Campos, et al.. (2003). Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival.. PubMed. 9(12). 4409–14. 103 indexed citations
20.
Campos, Eric I., et al.. (2002). The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines. British Journal of Dermatology. 146(4). 574–580. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026